Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2005 (Vol. 25, No. 13)

Parabiosys: Parallel Biological Systems

URL:pga.mgh.harvard.edu
  • Broad ranging information
  • A bit scattered
When it comes to “techie” sounding names, it doesn’t get much better than the MGH-PGA Parabiosys system whose subtitle is Parallel Biological Systems. Wow! What does that entail? Obviously, this could cover a lot of ground and the site makes no attempt to expand beyond the scope of the research projects it covers. Some of these include host-pathogen interactions, stress pathway signal transduction, and macrophage activation. Other topics covered on the site include protein networks/RNA display, bacterial pathogen resources, and software tools developed in the project. There is a section devoted to education and enough pieces of miscellany (including PowerPoint presentations, online analysis of sequences, and generous policies on data sharing) to make the site worth a good look.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »